We are live on ! Find out more
NIP

Nicholas Investment Partners Portfolio holdings

AUM $1.39B
1-Year Est. Return 97.11%
This Fund
S&P 500
This Quarter Est. Return
-2.08%
1 Year Est. Return
+97.11%
3 Year Est. Return
+361.61%
5 Year Est. Return
+496.81%
10 Year Est. Return
+3,647.83%
AUM
$971M
AUM Growth
-$166M
Cap. Flow
-$152M
Cap. Flow %
-15.64%
Top 10 Hldgs %
19.56%
Holding
242
New
33
Increased
69
Reduced
52
Closed
50

Top Buys

Rank Stock Value
1
XLV icon
State Street Health Care Select Sector SPDR ETF
XLV
+$13.3M
2
GH icon
Guardant Health
GH
+$10.1M
3
NCLH icon
Norwegian Cruise Line
NCLH
+$8.18M
4
EXLS icon
EXL Service
EXLS
+$7.81M
5
RSI icon
Rush Street Interactive
RSI
+$7.55M

Top Sells

Rank Stock Value
1
EVR icon
Evercore
EVR
+$20M
2
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$14.8M
3
TFII icon
TFI International
TFII
+$14.5M
4
CORZ icon
Core Scientific
CORZ
+$13.4M
5
FTAI icon
FTAI Aviation
FTAI
+$12.9M

Sector Composition

Rank Sector Weight
1 Industrials 20.23%
2 Technology 20.07%
3 Healthcare 16.69%
4 Consumer Discretionary 9.79%
5 Financials 9.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
C icon
101
Citigroup
C
$226B
$2.91M 0.3%
41,000
+1,000
+3% +$76.3K
SNOW icon
102
Snowflake
SNOW
$115B
$2.9M 0.3%
+19,837
New +$3.37M
VRSK icon
103
Verisk Analytics
VRSK
$25B
$2.77M 0.29%
+9,307
New +$2.68M
WMB icon
104
Williams Companies
WMB
$86.1B
$2.75M 0.28%
46,000
– –
ALAB icon
105
Astera Labs
ALAB
$58B
$2.74M 0.28%
45,850
-103,421
-69% -$9.57M
KLAC icon
106
KLA
KLAC
$259B
$2.65M 0.27%
38,960
-3,870
-9% -$279K
NVMI
107
Nova
NVMI
$12.5B
$2.64M 0.27%
14,323
+1,112
+8% +$257K
MCHPP
108
Microchip Technology Inc 7.50% Series A Preferred Stock
MCHPP
– –
0
– –
VRT icon
109
Vertiv
VRT
$105B
$2.62M 0.27%
36,294
+35
+0.1% +$3.73K
MC icon
110
Moelis & Co
MC
$4.94B
$2.52M 0.26%
+43,101
New +$3.04M
SPSC icon
111
SPS Commerce
SPSC
$2.64B
$2.49M 0.26%
18,789
-20,450
-52% -$3.21M
NET icon
112
Cloudflare
NET
$107B
$2.49M 0.26%
22,109
+11,519
+109% +$1.53M
ONTO icon
113
Onto Innovation
ONTO
$15.3B
$2.38M 0.25%
19,646
-21,320
-52% -$3.59M
TXRH icon
114
Texas Roadhouse
TXRH
$13.7B
$2.33M 0.24%
13,993
+11,820
+544% +$2.09M
VERA icon
115
Vera Therapeutics
VERA
$2.36B
$2.29M 0.24%
95,402
-11,403
-11% -$366K
NLY icon
116
Annaly Capital Management
NLY
$17.4B
$2.17M 0.22%
106,805
-33,330
-24% -$686K
BAH icon
117
Booz Allen Hamilton
BAH
$9.15B
$2.16M 0.22%
20,698
-897
-4% -$108K
RVMD icon
118
Revolution Medicines
RVMD
$44B
$2.16M 0.22%
61,123
-23,606
-28% -$958K
COP icon
119
ConocoPhillips
COP
$141B
$2.1M 0.22%
20,000
– –
CVLT icon
120
Commault Systems
CVLT
$5.61B
$2.01M 0.21%
+12,744
New +$2.1M
PL icon
121
Planet Labs
PL
$8.53B
$1.97M 0.2%
+583,237
New +$2.73M
CW icon
122
Curtiss-Wright
CW
$25.5B
$1.97M 0.2%
6,194
+16
+0.3% +$5.4K
PLTR icon
123
Palantir
PLTR
$413B
$1.86M 0.19%
+22,075
New +$1.94M
MLTX icon
124
MoonLake Immunotherapeutics
MLTX
$1.55B
$1.83M 0.19%
+46,933
New +$2.02M
CACI icon
125
CACI
CACI
$14.2B
$1.83M 0.19%
4,979
-5,659
-53% -$2.17M
3 4
5
6 7

Similar funds

FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return
OCM
Opti Capital Management New York $1.39B AUM 0% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
TA
Trivest Advisors Hong Kong $1.39B AUM 273.03% 1-Year Est. Return
AU
Algebris (UK) London, United Kingdom $1.38B AUM 3.87% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
BCP
Blue Chip Partners Farmington Hills, Michigan $1.39B AUM 22.32% 1-Year Est. Return

Nicholas Investment Partners's Q1 2025 Portfolio in Review

As of Q1 2025, Nicholas Investment Partners held 242 positions worth $971M, down 15% from $1.14B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Nicholas Investment Partners withdrew a net $152M in Q1 2025, closing 50 positions and reducing 52 holdings. Its most notable exit was Intra-Cellular Therapies Inc., an estimated $14.8M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 20% of assets, down from 21% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Nicholas Investment Partners opened a new position in State Street Health Care Select Sector SPDR ETF worth $13.4M.

  • Nicholas Investment Partners's largest Q1 2025 buy was State Street Health Care Select Sector SPDR ETF: 91,756 shares worth $13.4M.
  • Nicholas Investment Partners added most to Rush Street Interactive in Q1 2025, an estimated $7.55M increase.
  • Nicholas Investment Partners's biggest Q1 2025 reduction was Evercore, cutting an estimated $20M.
  • Nicholas Investment Partners fully exited Intra-Cellular Therapies Inc. in Q1 2025, selling an estimated $14.8M.
  • Nicholas Investment Partners's ten largest holdings make up 20% of its $971M portfolio in Q1 2025.
  • Nicholas Investment Partners opened 33 new positions and closed 50 in Q1 2025.
  • Nicholas Investment Partners's portfolio value fell 15% quarter-over-quarter to $971M.

Based on Nicholas Investment Partners's 13F filing for Q1 2025, filed 15 May 2025.